215 related articles for article (PubMed ID: 34529278)
21. Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.
Ramakrishnan S; Cortes-Gomez E; Athans SR; Attwood KM; Rosario SR; Kim SJ; Mager DE; Isenhart EG; Hu Q; Wang J; Woloszynska A
Genome Med; 2024 Apr; 16(1):52. PubMed ID: 38566104
[TBL] [Abstract][Full Text] [Related]
22. Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men.
Powell IJ; Vigneau FD; Bock CH; Ruterbusch J; Heilbrun LK
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1505-11. PubMed ID: 24802741
[TBL] [Abstract][Full Text] [Related]
23. Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.
Teslow EA; Bao B; Dyson G; Legendre C; Mitrea C; Sakr W; Carpten JD; Powell I; Bollig-Fischer A
Mol Oncol; 2018 Jun; 12(7):1138-1152. PubMed ID: 29741809
[TBL] [Abstract][Full Text] [Related]
24. Tumor immunobiological differences in prostate cancer between African-American and European-American men.
Wallace TA; Prueitt RL; Yi M; Howe TM; Gillespie JW; Yfantis HG; Stephens RM; Caporaso NE; Loffredo CA; Ambs S
Cancer Res; 2008 Feb; 68(3):927-36. PubMed ID: 18245496
[TBL] [Abstract][Full Text] [Related]
25. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.
Leyten GH; Hessels D; Jannink SA; Smit FP; de Jong H; Cornel EB; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; van Oort IM; Mulders PF; Hulsbergen-van de Kaa CA; Schalken JA
Eur Urol; 2014 Mar; 65(3):534-42. PubMed ID: 23201468
[TBL] [Abstract][Full Text] [Related]
26. Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy.
Feibus AH; Sartor O; Moparty K; Chagin K; Kattan MW; Ledet E; Levy J; Lee B; Thomas R; Silberstein JL
J Urol; 2016 Oct; 196(4):1053-60. PubMed ID: 27140073
[TBL] [Abstract][Full Text] [Related]
27. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center.
Nie L; Pan X; Zhang M; Yin X; Gong J; Chen X; Xu M; Zhou Q; Chen N
Prostate; 2019 Jun; 79(8):819-825. PubMed ID: 30900303
[TBL] [Abstract][Full Text] [Related]
28. Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update.
Powell IJ; Chinni SR; Reddy SS; Zaslavsky A; Gavande N
Urol Oncol; 2021 Jan; 39(1):34-40. PubMed ID: 32900629
[TBL] [Abstract][Full Text] [Related]
29. Should African-American men be tested for prostate carcinoma at an earlier age than white men?
Powell IJ; Banerjee M; Sakr W; Grignon D; Wood DP; Novallo M; Pontes E
Cancer; 1999 Jan; 85(2):472-7. PubMed ID: 10023717
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of p16 expression among African American and European American prostate cancer patients.
Wong M; Bierman Y; Pettaway C; Kittles R; Mims M; Jones J; Ittmann M
Prostate; 2019 Aug; 79(11):1274-1283. PubMed ID: 31111520
[TBL] [Abstract][Full Text] [Related]
31. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J
Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102
[TBL] [Abstract][Full Text] [Related]
32. Frequency of PTEN alterations, TMPRSS2-ERG fusion and their association in prostate cancer.
Fallahabadi ZR; Noori Daloii MR; Mahdian R; Behjati F; Shokrgozar MA; Abolhasani M; Asgari M; Shahrokh H
Gene; 2016 Jan; 575(2 Pt 3):755-60. PubMed ID: 26424596
[TBL] [Abstract][Full Text] [Related]
33. Racial disparity in the genomics of precision oncology of prostate cancer.
Le T; Rojas PS; Fakunle M; Huang FW
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1867. PubMed ID: 37565547
[TBL] [Abstract][Full Text] [Related]
34. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients.
Stevens C; Hightower A; Buxbaum SG; Falzarano SM; Rhie SK
Front Oncol; 2023; 13():1079037. PubMed ID: 36937425
[TBL] [Abstract][Full Text] [Related]
35. Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer.
Cornu JN; Cancel-Tassin G; Egrot C; Gaffory C; Haab F; Cussenot O
Prostate; 2013 Feb; 73(3):242-9. PubMed ID: 22821767
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
Mosquera JM; Mehra R; Regan MM; Perner S; Genega EM; Bueti G; Shah RB; Gaston S; Tomlins SA; Wei JT; Kearney MC; Johnson LA; Tang JM; Chinnaiyan AM; Rubin MA; Sanda MG
Clin Cancer Res; 2009 Jul; 15(14):4706-11. PubMed ID: 19584163
[TBL] [Abstract][Full Text] [Related]
37. miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.
Yates C; Long MD; Campbell MJ; Sucheston-Campbell L
Front Biosci (Landmark Ed); 2017 Jan; 22(2):212-229. PubMed ID: 27814612
[TBL] [Abstract][Full Text] [Related]
38. Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status.
Geybels MS; McCloskey KD; Mills IG; Stanford JL
Prostate; 2017 Feb; 77(3):282-290. PubMed ID: 27753122
[TBL] [Abstract][Full Text] [Related]
39. Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities.
Ramirez-Torres A; Reagan AL; Howard LE; Wiggins E; Vidal AC; Wan J; Miller B; Freedland SJ; Cohen P
Prostate; 2022 Sep; 82(13):1248-1257. PubMed ID: 35789022
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.
Dhani NC; Emmenegger U; Adams L; Jongstra J; Tannock IF; Sridhar SS; Knox JJ; Day JR; Groskopf J; Joshua AM
BJU Int; 2012 Sep; 110(6):840-5. PubMed ID: 22313860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
